American Society of Clinical Oncology

SHERPA: White

People

  1. McBride
    McBride
  2. Lee
    Lee
  3. Riaz
    Riaz
  4. Sherman
    Sherman
  5. Wolden
    Wolden
  6. Baxi
    Baxi
  7. Boyle
    Boyle
  8. Cheung
    Cheung
  9. Kollmeier
    Kollmeier
  10. Kushner
    Kushner

Groups

  1. Radiation Oncology, Department of (17)
  2. Survivorship Research (12)
  3. Department of Medicine (11)
  4. Solid Tumor Oncology Division (10)
  5. Head and Neck Service (7)
  6. Population Sciences Research Program (6)
  7. Surgery (6)
  8. Radiology, Department of (5)
  9. Center for Hematologic Malignancies (4)
  10. Pediatric Leukemia (4)
Search Within
  1. "Radiation Oncology, Department of"
  2. "2016"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (2)
Groups
  1. Radiation Oncology, Department of (17)
  2. Survivorship Research (12)
  3. Department of Medicine (11)
  4. Solid Tumor Oncology Division (10)
  5. Head and Neck Service (7)
  6. Population Sciences Research Program (6)

More Groups

People
  1. Sean McBride (8)
  2. Eric Sherman (6)
  3. Nadeem Riaz (6)
  4. Nancy Lee (6)
  5. Suzanne Wolden (4)
  6. Shrujal Baxi (3)

More People

Years
  1. 2016 (17)
Publications
  1. Journal of Clinical Oncology (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Toxicity and efficacy of concomitant chemoradiotherapy (CCRT) in elderly patients with oropharyngeal carcinoma (OPC) in the intensity modulated radiotherapy (IMRT) era
    Meeting Abstract

    Zumsteg, Z. S.; Lok, B. H.; Ho, A. S.; Riaz, N.; Shiao, S. L.; McBride, S. M.; Tsai, C. J.; Baxi, S. S.; Sherman, E. J.; Lee, N. Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Radiation therapy and low dose doxorubicin in thyroid cancer: A phase II study
    Meeting Abstract

    Sherman, E. J.; Romesser, P. B.; Ho, A. L.; Baxi, S. S.; Riaz, N.; McBride, S. M.; Chan, S.; Tuttle, R. M.; Pfister, D. G.; Lee, N. Y.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Non-randomized phase II study to assess the efficacy of pembrolizumab (Pem) plus radiotherapy (RT) or ablation in mismatch repair proficient (pMMR) metastatic colorectal cancer (mCRC) patients
    Meeting Abstract

    Segal, N. H.; Kemeny, N. E.; Cercek, A.; Reidy, D. L.; Raasch, P. J.; Warren, P.; Hrabovsky, A. E.; Campbell, N.; Shia, J.; Goodman, K. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Phase IB trial of carboxyamidotriazole orotate (CTO) and radiotherapy (RT) with concurrent and adjuvant temozolomide (TMZ) in newly diagnosed glioblastoma (GBM)
    Meeting Abstract

    Omuro, A. M. P.; Beal, K.; McNeill, K. A.; Thomas, A. A.; Lin, X.; Kaley, T. J.; DeAngelis, L. M.; Mellinghoff, I. K.; Diamond, E. L.; Chan, T. A. T.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Proton radiotherapy for incurable recurrent or metastatic cancers of the head and neck by the RTOG 8502 hypofractionated palliative schedule
    Meeting Abstract

    Lok, B. H.; Zong, J.; Gutinov, S. I.; Cai, X.; Deselm, C.; Romesser, P. B.; Lanning, R. M.; Shcherba, M.; Xiao, H.; Sherman, E. J.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Comparison of outcomes following recurrence or metastasis in HPV plus and HPV-oropharyngeal carcinoma treated with definitive chemoradiation using IMRT
    Meeting Abstract

    Leeman, J. E.; Li, J. G.; Venigalla, P.; Zumsteg, Z. S.; McBride, S. M.; Boyle, J.; Roman, B. R.; Sherman, E. J.; Lee, N. Y.; Riaz, N.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Natural history following recurrence after definitive locoregional treatment in 1000+ cases of locally advanced head and neck squamous cell carcinoma
    Meeting Abstract

    Leeman, J. E.; Li, J. G.; Venigalla, P.; Zumsteg, Z. S.; McBride, S. M.; Boyle, J.; Roman, B. R.; Sherman, E. J.; Lee, N. Y.; Riaz, N.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Event-free survival (EFS) and overall survival (OS) of MYCN-amplified stage 2/3 neuroblastoma with or without autologous stem-cell transplantation (ASCT)
    Meeting Abstract

    Kushner, B. H.; Modak, S.; LaQuaglia, M. P.; Wolden, S. L.; Basu, E. M.; Roberts, S. S.; Kramer, K.; Cheung, I. Y.; Cheung, N. K. V.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • HPV cell free DNA as a marker of response to chemoradiation for HPV-positive oropharngeal cancers
    Meeting Abstract

    Higginson, D. S.; Damerla, R.; Scher, E. D.; Gutinov, S. I.; Thompson, C.; Cleary, C.; McBride, S. M.; Sherman, E. J.; Riaz, N.; Lee, N.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • 18F 2Fluoro-2deoxy-D-glucose positron emission tomography (FDG-PET) response to predict event-free survival (EFS) in intermediate risk (IR) or high risk (HR) rhabdomyosarcoma (RMS): A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group (COG)
    Meeting Abstract

    Harrison, D. J.; Parisi, M. T.; Shulkin, B. L.; Chi, Y. Y.; Anderson, J. R.; Mi, X.; Malempati, S.; Mascarenhas, L.; McCowage, G. B.; Weigel, B.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save